United Therapeutics | UTHR - Stock


United Therapeutics reported $193.8M in Stock for its fiscal quarter ending in June of 2026.





Stock Change Date
Amarin USD 164.07M 19.51M Jun/2026
Ardelyx USD 128.02M 110.29M Mar/2026
Baxter International USD 2.26B 57M Jun/2026
Bayer EUR 11.97B 43M Jun/2026
BioCryst Pharmaceuticals USD 6.06M 71K Jun/2026
Biogen USD 2.38B 435.3M Jun/2026
BioMarin Pharmaceutical USD 1.78B 509.3M Jun/2026
Emergent BioSolutions USD 328.9M 25.2M Dec/2023
Gilead Sciences USD 1.91B 140M Mar/2026
GlaxoSmithKline GBP 6.16B 233M Mar/2026
Halozyme Therapeutics USD 137.14M 18.33M Jun/2026
Insmed USD 142.38M 9.48M Jun/2026
Ionis Pharmaceuticals USD 50.83M 45.28M Jun/2026
J&J USD 15.14B 561M Jun/2026
Lexicon Pharmaceuticals USD 276K 5K Mar/2026
Moderna USD 280M 134M Jun/2026
Omeros USD 712K 266K Sep/2021
Pfizer USD 9.94B 722M Jun/2026
PTC Therapeutics USD 91.35M 15.79M Jun/2026
Regeneron Pharmaceuticals USD 3.08B 19.3M Jun/2026
Sarepta Therapeutics USD 904.27M 96.84M Jun/2026
Teva Pharmaceutical Industries USD 3.18B 3M Mar/2026
United Therapeutics USD 193.8M 15.5M Jun/2026
Vertex Pharmaceuticals USD 1.77B 1.6M Jun/2026